Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
25.83
+0.29 (1.14%)
Nov 17, 2026, 10:21 AM EST - Market open

Baxter International Revenue

Baxter International had revenue of $2.98B in the quarter ending September 30, 2026, with 4.97% growth. This brings the company's total for the last twelve months to $11.61B, up 5.33% year-over-year. In the year 2025, Baxter International had annual revenue of $11.24B with 5.72% growth. That makes Baxter International the 1,306th largest company in the world by revenue and 417th in the United States.

Revenue (ttm)
$11.61B
Revenue Growth
+5.33%
P/S Ratio
1.14
Revenue / Employee
$309,627
Employees
37,500
Market Cap
13.36B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Infusion Therapies & Platforms 4.10B 36.5%
  • Care & Connectivity Solutions 1.91B 17.0%
  • Injectables and Anesthesia 1.35B 12.0%
  • Advanced Surgery 1.20B 10.7%
  • Front Line Care 1.16B 10.3%
  • Drug Compounding 1.14B 10.1%
  • Other 381.00M 3.4%

By Geography

Chart
  • United States 6.12B 54.4%
  • Rest of World 3.73B 33.2%
  • Emerging Markets 1.39B 12.4%
Fiscal year ended Dec 31, 2025 See the full Baxter International breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202511.24B608.00M5.72%
Dec 31, 202410.64B276.00M2.66%
Dec 31, 202310.36B303.00M3.01%
Dec 31, 202210.06B-2.09B-17.20%
Dec 31, 202112.15B473.00M4.05%
Dec 31, 202011.67B311.00M2.74%
Dec 31, 201911.36B263.00M2.37%
Dec 31, 201811.10B515.00M4.87%
Dec 31, 201710.58B421.00M4.14%
Dec 31, 201610.16B195.00M1.96%
Dec 31, 20159.97B-751.00M-7.01%
Dec 31, 201410.72B1.31B13.87%
Dec 31, 20139.41B-4.52B-32.46%
Dec 31, 201213.94B43.00M0.31%
Dec 31, 201113.89B1.05B8.18%
Dec 31, 201012.84B281.00M2.24%
Dec 31, 200912.56B214.00M1.73%
Dec 31, 200812.35B1.09B9.63%
Dec 31, 200711.26B885.00M8.53%
Dec 31, 200610.38B529.00M5.37%
Dec 31, 20059.85B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.